What laboratory tests are indicated for a hypercoagulable state work-up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A hypercoagulable work-up should include a complete blood count, prothrombin time, and activated partial thromboplastin time, as these are the initial recommended tests for evaluating suspected cerebral venous thrombosis 1. When evaluating a patient for hypercoagulability, it is essential to consider both inherited and acquired thrombophilias. The initial laboratory tests should include:

  • Complete blood count
  • Prothrombin time (PT)
  • Activated partial thromboplastin time (aPTT) Additional tests to consider include:
  • Factor V Leiden mutation
  • Prothrombin G20210A mutation
  • Protein C activity
  • Protein S activity
  • Antithrombin III activity
  • Lupus anticoagulant
  • Anticardiolipin antibodies
  • Beta-2 glycoprotein antibodies
  • Homocysteine levels
  • JAK2 V617F mutation testing It is crucial to note that the timing of testing is important, as acute thrombosis, inflammation, pregnancy, and anticoagulant therapy can affect results 1. Ideally, these tests should be performed at least 2-3 weeks after discontinuation of anticoagulation therapy and when the patient is not experiencing an acute thrombotic event. However, genetic tests like factor V Leiden and prothrombin gene mutation can be performed at any time. The evidence from 1 provides a foundation for the initial work-up, while also considering the comprehensive panel of tests that can help identify both common inherited thrombophilias and acquired conditions that increase clotting risk, allowing for appropriate management strategies to prevent recurrent thrombosis.

From the Research

Hypercoagulable Work-up Labs

The following labs are recommended for a hypercoagulable work-up:

  • Prothrombin time (PT) 2, 3
  • Activated partial thromboplastin time (APTT) 2, 3
  • Fibrinogen (FBG) assay 3
  • D-dimer (D-DI) assay 2, 3
  • Coagulation inhibitor levels, including:
    • Protein C (PC) 4, 2, 3
    • Protein S (PS) 4, 2, 3
    • Antithrombin 4, 2, 3
  • Tests for fibrinolysis, including:
    • Tissue plasminogen activator (tPA) 3
    • Plasminogen activator inhibitor type 1 (PAI-1) 3
  • Factor assays, including:
    • Factor II 2
    • Factor V 4, 2
    • Factor VII 2
    • Factor VIII 2
    • Factor IX 2
    • Factor X 2
    • Factor XI 2
    • Factor XII 2
  • Von Willebrand factor (vWF) antigen 2
  • vWF ristocetin cofactor 2
  • A disintegrin and metalloprotease with thrombospondin type 1 motifs 13 antigen 2
  • Prothrombin fragment F1+2 2
  • Activated factor VII 2
  • Clot lysis time 2
  • Endogenous thrombin potential (ETP) with and without thrombomodulin 2 Note that not all of these labs may be necessary for every patient, and the specific labs ordered may depend on the individual patient's clinical presentation and medical history 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2012

Research

Laboratory evaluation of hypercoagulability.

Clinics in laboratory medicine, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.